SEC Form DFiling only, no announcement found
SymKardia, based in Westlake, OH, reported $4,300,000 sold in a private offering of debt and Convertible notes and equity issuable upon any conversion thereof, with the first sale on June 8, 2026, in a Form D filed with the SEC on October 28, 2026. The filing says 3 investors have already invested. The offering authorizes up to $12,000,000.
Legal name on the filing: SymKardia, Inc..
| Amount sold | $4,300,000Basis: Form D total amount sold, as of the filing of October 28, 2026. Not the announced round size. |
|---|---|
| Total offering | $12,000,000The most the company may sell under this offering. Not money raised. |
| Remaining to be sold | $7,700,000 |
| Securities offered | Debt; Other (Convertible notes and equity issuable upon any conversion thereof) |
| Exemption claimed | Rule 506(b) |
| Date of first sale | June 8, 2026 |
| Investors already invested | 3 |
| Non-accredited investors | None |
| Minimum investment accepted | $0 |
| Part of a merger or acquisition | No |
| Industry group | Other Health Care |
| Principal place of business | Westlake, OH |
| Jurisdiction of incorporation | DELAWARE |
| Entity type | Corporation |
| Year of incorporation | 2024 |
| Revenue range | Decline to Disclose |
| SEC CIK | 2141283 |
Round name, valuation, lead investor and participants are not on a Form D, so they are not shown. They appear here only when a press or company announcement is matched to this deal.
| Name, as filed | Relationship | VC Beast profile |
|---|---|---|
| Anthony Caparso | Executive Officer, Director | None linked |
| Bruce KenKnight | Executive Officer | None linked |
| Steven Girouard | Executive Officer | None linked |
| Jonathan Piccini | Executive Officer | None linked |
| Imad Libbus | Executive Officer | None linked |
| Dwight Skinner | Executive Officer | None linked |
| Robert Picarel | Director | None linked |
| Arun Sridhar | Director | None linked |
| Claudio Rumazza | Director | None linked |
| Alain Garcinuno Collet | Director | None linked |
| James Blouzard | Director | None linked |
Form D lists the company's executive officers, directors and promoters. A director is often an investor's board representative, but the filing does not say who invested.
| Filed | Form | Amount sold | Total offering |
|---|---|---|---|
| Oct 28, 2026 | D/A (amendment) | $4,300,000 | $12,000,000 |
The latest filing states the current amount sold; an amendment replaces the figure before it.
From the issuer's EDGAR filing history. Amounts are shown for filings in our warehouse, which holds operating-company filings from July 16, 2026.
Filing only, no announcement found. The only source for this deal is the company's own SEC filing, made under penalty of law. When a press or company announcement is matched to it, it is cited here with the round name it gives.
Amount sold is the filing's total amount sold; total offering is its authorized maximum. This page was built from filings received through October 28, 2026. Report an error on the corrections page.
Cite this deal
VC Beast, "SymKardia: SEC Form D deal record", https://vcbeast.com/deals/symkardia-form-d-2026-06-08. Source: SEC EDGAR, accession 0002141283-26-000003.